Hst Global, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 13, 2021 at 10:39 am EDT
Share
HST Global, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating loss was USD 38,217 compared to USD 43,822 a year ago. Net loss was USD 38,879 compared to USD 44,028 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago. For the half year, operating loss was USD 76,521 compared to USD 78,640 a year ago. Net loss was USD 77,618 compared to USD 78,862 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.02 a year ago.
HST Global, Inc. is an integrated health and wellness biotechnology company. The Company is focused on developing and /or acquiring a network of wellness centers worldwide that is primarily focused on the homeopathic and alternative treatment of late-stage cancer. The Company intends to acquire innovative products for the treatment of life-threatening diseases. The Company primarily focuses on homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late-stage cancer and/or life-threatening diseases. The Company has not generated any revenue.
HST GLOBAL, INC. 
